- Recent Funding
- Investors
- Danaher Ventures
Danaher Ventures portfolio
Danaher Ventures has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Automata's $45M Series B+ round in January 2026, which it led, alongside Entrepreneurs First, Octopus Ventures, Tru Arrow Partners and 1 other. By category, its portfolio leans toward Health and bio (2) and AI agents (1).
What Danaher Ventures invests in
- Health and bio · 2 · 100%
- AI agents · 1 · 50%
- Data and analytics · 1 · 50%
How Danaher Ventures invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $45M |
Danaher Ventures portfolio companies
AAutomata$45MSeries B+ · Jan 2026
IInnovaccerbacker
| Company | Round with Danaher Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $45M · lead | $95M | Jan 29, 2026 Series B+ |
AI agents |
backer | undisclosed | — |
Most frequent co-investors
TTru Arrow Partners1 shared round · last Jan 29, 2026
OOctopus Ventures1 shared round · last Jan 29, 2026
EEntrepreneurs First1 shared round · last Jan 29, 2026DDimension1 shared round · last Jan 29, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Danaher Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Danaher Ventures, which is a subset of its real portfolio. API: /api/v1/investors/danaher-ventures (get a free API key). More: the most active VC firms and new venture capital funds.